Bradford Amman
2021
In 2021, Bradford Amman earned a total compensation of $1.1M as Chief Financial Officer at Vivos Therapeutics, a 311% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $52,048 |
|---|---|
| Option Awards | $805,560 |
| Salary | $230,182 |
| Other | $18,302 |
| Total | $1,106,092 |
Amman received $805.6K in option awards, accounting for 73% of the total pay in 2021.
Amman also received $52K in non-equity incentive plan, $230.2K in salary and $18.3K in other compensation.
Rankings
In 2021, Bradford Amman's compensation ranked 8,438th out of 12,406 executives tracked by ExecPay. In other words, Amman earned more than 32.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,438 out of 12,406 | 32nd |
Division Manufacturing | 3,731 out of 5,494 | 32nd |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 475 out of 798 | 41st |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 299 out of 519 | 42nd |
Industry Surgical and Medical Instruments and Apparatus | 190 out of 324 | 41st |
Source: SEC filing on July 14, 2022.
Amman's colleagues
We found two more compensation records of executives who worked with Bradford Amman at Vivos Therapeutics in 2021.